Clinical Trial Update: Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating pharmacokinetics and safety of N8 versus Advate in Haemophilia A subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• ADVATE (antihemophilic factor VIII)
• N8

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 1 | Status: COMPLETED